Details

Klinični pomen določanja prekurzorja prostatno specifičnega antigena pri bolnikih z nizko celokupno plazemsko koncentracijo specifičnega antigena : magistrski študij laboratorijske biomedicine
ID Bizjak, Mitja (Author), ID Osredkar, Joško (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/bizjak_mitja_mag_nal_2016.pdf?sfvrsn=2 This link opens in a new window

Language:Slovenian
Keywords:rak prostate, prostatično specifični antigen, prostatični indeks, razmerje med koncntracijo prostega PSA in celotnega PSA, tumorski označevalec, določanje prekurzorja
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[M. Bizjak]
Year:2016
Number of pages:VIII, 59 f.
PID:20.500.12556/RUL-87336 This link opens in a new window
UDC:616.65-006(043.3)
COBISS.SI-ID:4116081 This link opens in a new window
Publication date in RUL:08.12.2016
Views:2663
Downloads:426
Metadata:XML DC-XML DC-RDF
:
BIZJAK, Mitja, 2016, Klinični pomen določanja prekurzorja prostatno specifičnega antigena pri bolnikih z nizko celokupno plazemsko koncentracijo specifičnega antigena : magistrski študij laboratorijske biomedicine [online]. Master’s thesis. Ljubljana : M. Bizjak. [Accessed 3 September 2025]. Retrieved from: http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/bizjak_mitja_mag_nal_2016.pdf?sfvrsn=2
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Clinical value of precursor prostate specific antigen in patients with low plasma concentration of prostate specific antigen

Similar documents

Similar works from RUL:
  1. Comparison of fecal microbiota of children with chronic inflammatory bowel disease and functional bowel disorders
  2. Kakovost življenja pri parih s kronično vnetno črevesno boleznijo ter relacijska družinska terapija
  3. Vitamin and mineral deficiency in patients with inflammatory bowel disease
  4. ǂThe ǂimportance of undetectable inflicamab t(h!)rough levels for clinical outcome of patients with inflammatory bowel disease
  5. Infliximab through as a biomarker for inflammatory bowel disease
Similar works from other Slovenian collections:
  1. Quality of life of children with chronic inflammatory bowel disease
  2. Izolacija in karakterizacija bakterije Clostridium difficile pri hospitaliziranih bolnikih s kronično vnetno črevesno boleznijo
  3. Expression and epigenetic profiles in patients with chronic inflammatory bowel disease
  4. Biomarkers of response to vedolizumab in inflammatory bowel diseases patients
  5. Nursing care of child with chronic inflammatory bowel (Crohn's disease)

Back